Business Description
Nutex Health Inc
NAICS : 622110
SIC : 8062
ISIN : US67079U3068
Total Employee Number:
944Compare
Compare
Traded in other countries / regions
NUTX.USA5LF.Germany Index Membership
Russell 2000Russell 3000Russell 3000Russell 2000 IPO Date
2022-04-04Description
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.59 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.88 | |||||
Debt-to-EBITDA | 0.9 | |||||
Interest Coverage | 18.42 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.16 | |||||
Beneish M-Score | -2.85 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 35.7 | |||||
3-Year FCF Growth Rate | 62.3 | |||||
3-Year Book Growth Rate | 28.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 30.36 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.57 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.26 | |||||
9-Day RSI | 54.48 | |||||
14-Day RSI | 56.26 | |||||
3-1 Month Momentum % | 20.58 | |||||
6-1 Month Momentum % | 79.52 | |||||
12-1 Month Momentum % | 94.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5 | |||||
Quick Ratio | 4.96 | |||||
Cash Ratio | 1.75 | |||||
Days Inventory | 3.04 | |||||
Days Sales Outstanding | 153.27 | |||||
Days Payable | 33.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.8 | |||||
Shareholder Yield % | 2.42 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 51.26 | |||||
Operating Margin % | 43.02 | |||||
Net Margin % | 21.25 | |||||
EBITDA Margin % | 45.38 | |||||
FCF Margin % | 32.38 | |||||
OCF Margin % | 33.02 | |||||
ROE % | 55.45 | |||||
ROA % | 19.36 | |||||
ROIC % | 46.12 | |||||
3-Year ROIIC % | 85.5 | |||||
ROC (Joel Greenblatt) % | 63.02 | |||||
ROCE % | 47.72 | |||||
Years of Profitability over Past 10-Year | 5 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 7.9 | |||||
Forward PE Ratio | 7.12 | |||||
PE Ratio without NRI | 7.9 | |||||
Price-to-Owner-Earnings | 6.29 | |||||
PS Ratio | 1.69 | |||||
PB Ratio | 3.45 | |||||
Price-to-Tangible-Book | 3.78 | |||||
Price-to-Free-Cash-Flow | 5.18 | |||||
Price-to-Operating-Cash-Flow | 5.1 | |||||
EV-to-EBIT | 4.45 | |||||
EV-to-EBITDA | 4.2 | |||||
EV-to-Revenue | 1.91 | |||||
EV-to-FCF | 5.89 | |||||
Price-to-GF-Value | 2.4 | |||||
Price-to-Graham-Number | 1.15 | |||||
| Price-to-Net-Current-Asset-Value | 88.69 | |||||
Earnings Yield (Greenblatt) % | 22.47 | |||||
FCF Yield % | 20.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NUTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nutex Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 846.72 | ||
| EPS (TTM) ($) | 25.16 | ||
| Beta | 2.1088 | ||
| 3-Year Sharpe Ratio | 0.84 | ||
| 3-Year Sortino Ratio | 2.32 | ||
| Volatility % | 77.31 | ||
| 14-Day RSI | 56.26 | ||
| 14-Day ATR ($) | 10.487565 | ||
| 20-Day SMA ($) | 187.929 | ||
| 12-1 Month Momentum % | 94.31 | ||
| 52-Week Range ($) | 80.53 - 204 | ||
| Shares Outstanding (Mil) | 6.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nutex Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nutex Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-03-05 09:30 | In 178 days | ||
| Annual report for 2026 | 2027-03-05 | In 177 days | ||
| Fourth quarter earnings results for 2026 | 2027-03-05 | In 177 days | ||
| Third quarter earnings conference call for 2026 | 2026-12-02 10:30 | In 85 days | ||
| Third quarter earnings results for 2026 | 2026-12-02 | In 84 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 09:30 | 151.93 (-2.88%) | ||
| Second quarter earnings results for 2026 | 2026-08-06 | 157.26 (-0.79%) | ||
| First quarter earnings conference call for 2026 | 2026-05-01 09:30 | 119.20 (+4.84%) | ||
| First quarter earnings results for 2026 | 2026-04-30 | 112.02 (-2.59%) | ||
| General meeting for 2026 | 2026-04-23 10:00 | 108.39 (+0.88%) |
Show
Entries
Nutex Health Inc Frequently Asked Questions
What is Nutex Health Inc(NUTX)'s stock price today?
The current price of NUTX is $198.66. The 52 week high of NUTX is $204.00 and 52 week low is $80.53.
When is next earnings date of Nutex Health Inc(NUTX)?
The next earnings date of Nutex Health Inc(NUTX) is 2026-12-02 Est..
Does Nutex Health Inc(NUTX) pay dividends? If so, how much?
Nutex Health Inc(NUTX) does not pay dividend.
Guru Commentaries on NAS:NUTX
Forager Fund
Bullish
2026 Q2
Annual Report Forager 2026 FINAL
What the manager wrote
Nutex Health (NASDAQ:NUTX) was the Fund’s largest contributor last year, and is continuing to add to returns, driving 1.1% of performance this year. The company’s share price is up another 37%, as the business keeps rolling out new hospital facilities and generating strong cash flows. While it’s not as cheap as it was, there is more evidence that our thesis is playing out, the balance sheet is stronger and near-term cash flows are higher. Nutex remains a meaningful investment for the Fund.
Forager Australian Shares Fund
Bullish
2025 Q2
What the manager wrote
Nutex Health has emerged as the largest single contributor to the Fund this year, showcasing a significant turnaround after being initially purchased when it was priced for insolvency. The company has demonstrated early signs of recovery, including arbitration wins against insurers and improving unit economics. The standout fourth quarter confirmed Nutex's ability to generate meaningful free cash flow and scale profitably, leading to a doubling of the position size as evidence of its turnaround strengthened. The share price surged more than tenfold from the initial purchase price, reflecting the successful execution of the investment thesis.
Press Release
Articles on Nutex Health Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers